City of Hope Global Oncology Symposium
City of Hope would like to invite you to the Global Oncology Symposium on Oncogenic Viruses. This Symposium will showcase four sessions with a blend of in-person and virtual speakers, ensuring a comprehensive perspective from cancer control in lower-middle-income countries to taking a deep dive into molecular mechanisms and therapies. Each session consists of presentations from our expert panelists, followed by a Q&A.
Agenda
October 27, 2023
8:30 a.m. to 3:00 p.m. Pacific Daylight Time
3:30 p.m. to 10:00 p.m. Greenwich Mean Time
4:30 p.m. to 11:00 p.m. Central European Time
Check-in and Breakfast | 8:00 a.m. – 8:30 a.m.
Opening Session | 8:30 a.m. – 8:45 a.m.
- 8:30 a.m. - 8:35 a.m. | Javier Gordon Ogembo, Ph.D., Welcome Remarks
- 8:35 a.m. - 8:45 a.m. | John Carpten, Ph.D., Opening Address
Director, Global Oncology Initiative,
Associate Professor, Department of Immuno-Oncology, City of Hope
Chief Scientific Officer, Irell & Manella Cancer Center. Director's Distinguished Chair, Morgan & Helen Chu Director's Chair of the Beckman Research Institute. Director, Comprehensive Cancer Center. Director, Beckman Research Institute of City of Hope
Session Chair: Narissa Nonzee, Ph.D. & Javier Gordon Ogembo, Ph.D.
- 8:50 a.m. - 9:15 a.m. | Douglas R. Lowy, M.D. Keynote Address: Controlling Cancer in Low-and-Middle Income Countries: The Example of Cervical Cancer
- 9:15 a.m. - 9:40 a.m | Satish Gopal, M.D., M.P.H., Alleviating EBV & KSHV-Mediated Suffering in Africa
- 9:40 a.m. - 9:45 a.m. | Q&A
Narissa Nonzee, Ph.D.
Assistant Professor, Division of Health Equities, Department of Population Sciences, City of Hope
Director, Global Oncology Initiative, Associate Professor, Department of Immuno-Oncology, City of Hope
Douglas R. Lowy M.D.
Principal Deputy Director, National Cancer Institute (NCI), Head of Signaling and Oncogenesis Section, Chief of Laboratory of Cellular Oncology, NCI Center for Cancer Research, National Institutes of Health, MD, USA
Director, Center for Global Health, National Cancer Institute,
National Institutes of Health, MD, USA.
Session Chair: Don J. Diamond, Ph.D.
- 10:00 a.m. - 10:25 a.m. | Christian Münz, PhD., Immune control of oncogenic human gamma-herpesviruses
- 10:25 a.m. - 10:50 a.m. | Julia Li, PhD., A previously missing link between Epstein Barr Virus and cancer
- 10:50 a.m. - 11:15 a.m. | Jeffrey Cohen, MD., Use of Vaccines and Monoclonal Antibodies to Prevent Epstein-Barr Virus Infection and Disease
- 11:15 a.m. - 11:30 a.m. | Q&A
Don J. Diamond, Ph.D.
Professor, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope
Professor, Institute of Experimental Immunology, University of Zurich, Switzerland
Damon Runyon Postdoctoral Fellow, Don Cleveland Lab, University of California San Diego, USA.
Chief, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA.
Lunch — 11:30 a.m. - 12:10 p.m.
Session Chair: Ana I. Tergas, M.D., M.P.H.
- 12:10 p.m. - 12:35 p.m. | Patricia Gordon, M.D., Community-Based HPV Testing & Treatment Program in Kenya
- 12:35 p.m. - 1:00 p.m. | Rebecca Lepsik, R.N., B.S., B.A., Community-Based HPV Testing & Treatment Program in Kenya
- 1:00 p.m. - 1:10 p.m. | Q&A
Ana I. Tergas, M.D.
Assistant Professor,
Department of Surgery, Division of Gynecologic Oncology, Department of Population Sciences, Division of Health Equities, City of Hope
Patricia Gordon, M.D.
Founding Director and Chair of the Board,
CureCervicalCancer Organization, CA, USA
Rebecca Lepsik, R.N., B.S., B.A.
Executive Director, CureCervicalCancer Organization, CA, USA
Session Chair: Laleh Melstrom, M.D., M.S.
- 1:20 p.m. - 1:45 p.m. | Michael J. Sofia, Ph.D., FRSC, Curing Chronic Viral Hepatitis: A Story of Transformational Success and Another of Enduring Hope
- 1:45 p.m. - 2:10 p.m. | Antonio Bertoletti, M.D., Adoptive T cell therapy against HBV-related Hepatocellular carcinoma
- 2:10 p.m. - 2:20 p.m. | Q&A
Chief, Division of Surgical Oncology, Department of Surgery,
Associate Professor of Surgery and Immuno-Oncology, City of Hope
Chief Scientific Officer & Co-Founder, Arbutus Biopharma, Inc.
PA, USA.
Antonio Bertoletti, M.D.
Professor, Duke-NUS Medical School,
Signature Research Program - Emerging Infectious Diseases, Singapore
Closing remarks | 2:20 p.m. - 2:30 p.m.
Stephen Gruber, M.D., Ph.D., M.P.H.
Vice President, City of Hope National Medical Center. Eva and Ming Hsieh Family Director’s Chair of the Center for Precision Medicine. Professor, Division of Molecular Pharmacology, Department of Medical Oncology & Therapeutics Research, City of Hope